Atherogenic and pulmonary responses of ApoE- and LDL receptor-deficient mice to sidestream cigarette smoke

Toxicology

Volumn 299, Issue 2-3, 2012, Pages 133-138

  Han, Sung Gu ^a   Howatt, Deborah A ^b   Daugherty, Alan ^a,b   Gairola, C Gary ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

ApoE deficient mice; Atherosclerosis; Cigarette smoke; LDL receptor deficient mice; Serum cholesterol concentration

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; CIGARETTE SMOKE; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LACTATE DEHYDROGENASE; LOW DENSITY LIPOPROTEIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL REACTIVITY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; INTIMA; LIPID COMPOSITION; LIPID OXIDATION; LIPOPROTEIN BLOOD LEVEL; LONG TERM EXPOSURE; LUNG INJURY; LUNG LAVAGE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BRONCHOALVEOLAR LAVAGE FLUID; CHOLESTEROL; FEMALE; INTERLEUKIN-1BETA; INTERLEUKIN-6; L-LACTATE DEHYDROGENASE; LUNG; MICE; MICE, KNOCKOUT; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RANDOM ALLOCATION; RECEPTORS, LDL; TOBACCO SMOKE POLLUTION; TUMOR NECROSIS FACTOR-ALPHA; TUNICA INTIMA;

MUS;

EID: 84862854974     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2012.05.015     Document Type: Article

References (50)

1. Abegunde D.O., Mathers C.D., Adam T., Ortegon M., Strong K. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet 2007, 370:1929-1938.
2. Almolki A., Guenegou A., Golda S., Boyer L., Benallaoua M., Amara N., Bachoual R., Martin C., Rannou F., Lanone S., Dulak J., Burgel P.R., El-Benna J., Leynaert B., Aubier M., Boczkowski J. Heme oxygenase-1 prevents airway mucus hypersecretion induced by cigarette smoke in rodents and humans. Am. J. Pathol. 2008, 173:981-992.
3. Ambrose J.A., Barua R.S. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J. Am. Coll. Cardiol. 2004, 43:1731-1737.
4. Armani C., Landini L., Leone A. Molecular and biochemical changes of the cardiovascular system due to smoking exposure. Curr. Pharm. Des. 2009, 15:1038-1053.
5. Betsuyaku T., Hamamura I., Hata J., Takahashi H., Mitsuhashi H., Adair-Kirk T.L., Senior R.M., Nishimura M. Bronchiolar chemokine expression is different after single versus repeated cigarette smoke exposure. Respir. Res. 2008, 9:7.
6. Breslow J.L. Mouse models of atherosclerosis. Science 1996, 272:685-688.
7. Bridges J.P., Davis H.W., Damodarasamy M., Kuroki Y., Howles G., Hui D.Y., McCormack F.X. Pulmonary surfactant proteins A and D are potent endogenous inhibitors of lipid peroxidation and oxidative cellular injury. J. Biol. Chem. 2000, 275:38848-38855.
8. Burke A., Fitzgerald G.A. Oxidative stress and smoking-induced vascular injury. Prog. Cardiovasc. Dis. 2003, 46:79-90.
9. Catanzaro D.F., Zhou Y., Chen R., Yu F., Catanzaro S.E., De Lorenzo M.S., Subbaramaiah K., Zhou X.K., Pratico D., Dannenberg A.J., Weksler B.B. Potentially reduced exposure cigarettes accelerate atherosclerosis: evidence for the role of nicotine. Cardiovasc. Toxicol. 2007, 7:192-201.
10. Chen H., Hansen M.J., Jones J.E., Vlahos R., Anderson G.P., Morris M.J. Detrimental metabolic effects of combining long-term cigarette smoke exposure and high-fat diet in mice. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E1564-E1571.
11. Chen L.C., Quan C., Hwang J.S., Jin X., Li Q., Zhong M., Rajagopalan S., Sun Q. Atherosclerosis lesion progression during inhalation exposure to environmental tobacco smoke: a comparison to concentrated ambient air fine particles exposure. Inhal. Toxicol. 2010, 22:449-459.
12. Conklin D.J., Barski O.A., Lesgards J.F., Juvan P., Rezen T., Rozman D., Prough R.A., Vladykovskaya E., Liu S., Srivastava S., Bhatnagar A. Acrolein consumption induces systemic dyslipidemia and lipoprotein modification. Toxicol. Appl. Pharmacol. 2010, 243:1-12.
13. D'Hulst A.I., Maes T., Bracke K.R., Demedts I.K., Tournoy K.G., Joos G.F., Brusselle G.G. Cigarette smoke-induced pulmonary emphysema in scid-mice. Is the acquired immune system required?. Respir. Res. 2005, 6:147.
14. Damjanovic M., Barton M. Fat intake and cardiovascular response. Curr. Hypertens. Rep. 2008, 10:25-31.
15. Daugherty A. Mouse models of atherosclerosis. Am. J. Med. Sci. 2002, 323:3-10.
16. Daugherty A., Rateri D.L. Development of experimental designs for atherosclerosis studies in mice. Methods 2005, 36:129-138.
17. Evans C.M., Kim K., Tuvim M.J., Dickey B.F. Mucus hypersecretion in asthma: causes and effects. Curr. Opin. Pulm. Med. 2009, 15:4-11.
18. Gairola C.G. Free lung cell response of mice and rats to mainstream cigarette smoke exposure. Toxicol. Appl. Pharmacol. 1986, 84:567-575.
19. Gairola C.G., Drawdy M.L., Block A.E., Daugherty A. Sidestream cigarette smoke accelerates atherogenesis in apolipoprotein E -/- mice. Atherosclerosis 2001, 156:49-55.
20. Gairola C.G., Howatt D.A., Daugherty A. Dietary coenzyme Q10 does not protect against cigarette smoke-augmented atherosclerosis in apoE-deficient mice. Free Radic. Biol. Med. 2010, 48:1535-1539.
21. Glantz S.A., Parmley W.W. Passive smoking and heart disease, epidemiology, physiology, and biochemistry. Circulation 1991, 83:1-12.
22. Glantz S.A., Parmley W.W. Passive smoking and heart disease mechanisms and risk. JAMA 1995, 273:1047-1053.
23. Han M.K., McLaughlin V.V., Criner G.J., Martinez F.J. Pulmonary diseases and the heart. Circulation 2007, 116:2992-3005.
24. Han S.G., Andrews R., Gairola C.G. Acute pulmonary response of mice to multi-wall carbon nanotubes. Inhal. Toxicol. 2010, 22:340-347.
25. Hawgood S., Clements J.A. Pulmonary surfactant and its apoproteins. J. Clin. Invest. 1990, 86:1-6.
26. He J., Vupputuri S., Allen K., Prerost M.R., Hughes J., Whelton P.K. Passive smoking and the risk of coronary heart disease-a meta-analysis of epidemiologic studies. N. Engl. J. Med. 1999, 340:920-926.
27. Hoffmann D., Hoffmann I., El-Bayoumy K. The less harmful cigarette: a controversial issue. a tribute to Ernst L. Wynder. Chem. Res. Toxicol. 2001, 14:767-790.
28. Hogg J.C., van Eeden S. Pulmonary and systemic response to atmospheric pollution. Respirology 2009, 14:336-346.
29. Honda Y., Takahashi H., Kuroki Y., Akino T., Abe S. Decreased contents of surfactant proteins A and D in BAL fluids of healthy smokers. Chest 1996, 109:1006-1009.
30. Howard G., Wagenknecht L.E., Burke G.L., Diez-Roux A., Evans G.W., McGovern P., Nieto F.J., Tell G.S. Cigarette smoking and progression of atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) study. JAMA 1998, 279:119-124.
31. Jawien J., Nastalek P., Korbut R. Mouse models of experimental atherosclerosis. J. Physiol. Pharmacol. 2004, 55:503-517.
32. Joven J., Rull A., Ferre N., Escola-Gil J.C., Marsillach J., Coll B., Alonso-Villaverde C., Aragones G., Claria J., Camps J. The results in rodent models of atherosclerosis are not interchangeable: the influence of diet and strain. Atherosclerosis 2007, 195:e85-e92.
33. Kido H., Sakai K., Kishino Y., Tashiro M. Pulmonary surfactant is a potential endogenous inhibitor of proteolytic activation of Sendai virus and influenza A virus. FEBS Lett. 1993, 322:115-119.
34. King V.L., Cassis L.A., Daugherty A. Interleukin-4 does not influence development of hypercholesterolemia or angiotensin II-induced atherosclerotic lesions in mice. Am. J. Pathol. 2007, 171:2040-2047.
35. Knight-Lozano C.A., Young C.G., Burow D.L., Hu Z.Y., Uyeminami D., Pinkerton K.E., Ischiropoulos H., Ballinger S.W. Cigarette smoke exposure and hypercholesterolemia increase mitochondrial damage in cardiovascular tissues. Circulation 2002, 105:849-854.
36. Leone A. Relationship between cigarette smoking and other coronary risk factors in atherosclerosis: risk of cardiovascular disease and preventive measures. Curr. Pharm. Des. 2003, 9:2417-2423.
37. Li Y.T., He B., Wang Y.Z. Exposure to cigarette smoke upregulates AP-1 activity and induces TNF-alpha overexpression in mouse lungs. Inhal. Toxicol. 2009, 21:641-647.
38. Lloyd-Jones D., Adams R.J., Brown T.M., Carnethon M., Dai S., De Simone G., Ferguson T.B., Ford E., Furie K., Gillespie C., Go A., Greenlund K., Haase N., Hailpern S., Ho P.M., Howard V., Kissela B., Kittner S., Lackland D., Lisabeth L., Marelli A., McDermott M.M., Meigs J., Mozaffarian D., Mussolino M., Nichol G., Roger V.L., Rosamond W., Sacco R., Sorlie P., Thom T., Wasserthiel-Smoller S., Wong N.D., Wylie-Rosett J. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010, 121:e46-e215.
39. Madamanchi N.R., Vendrov A., Runge M.S. Oxidative stress and vascular disease. Arterioscler. Thromb. Vasc. Biol. 2005, 25:29-38.
40. Naura A.S., Hans C.P., Zerfaoui M., Errami Y., Ju J., Kim H., Matrougui K., Kim J.G., Boulares A.H. High-fat diet induces lung remodeling in ApoE-deficient mice: an association with an increase in circulatory and lung inflammatory factors. Lab. Invest. 2009, 89:1243-1251.
41. Ockene I.S., Miller N.H. Cigarette smoking, cardiovascular disease, and stroke: a statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction. Circulation 1997, 96:3243-3247.
42. Packard R.R., Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin. Chem. 2008, 54:24-38.
43. Raupach T., Schafer K., Konstantinides S., Andreas S. Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm. Eur. Heart J. 2006, 27:386-392.
44. Rodgman A., Smith C.J., Perfetti T.A. The composition of cigarette smoke: a retrospective, with emphasis on polycyclic components. Hum. Exp. Toxicol. 2000, 19:573-595.
45. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 1999, 340:115-126.
46. von Holt K., Lebrun S., Stinn W., Conroy L., Wallerath T., Schleef R. Progression of atherosclerosis in the ApoE -/- model: 12-month exposure to cigarette mainstream smoke combined with high-cholesterol/fat diet. Atherosclerosis 2009, 205:135-143.
47. Willett W.C., Green A., Stampfer M.J., Speizer F.E., Colditz G.A., Rosner B., Monson R.R., Stason W., Hennekens C.H. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N. Engl. J. Med. 1987, 317:1303-1309.
48. Yanbaeva D.G., Dentener M.A., Creutzberg E.C., Wesseling G., Wouters E.F. Systemic effects of smoking. Chest 2007, 131:1557-1566.
49. Yuan H., Wong L.S., Bhattacharya M., Ma C., Zafarani M., Yao M., Schneider M., Pitas R.E., Martins-Green M. The effects of second-hand smoke on biological processes important in atherogenesis. BMC Cardiovasc. Disord. 2007, 7:1.
50. Zadelaar S., Kleemann R., Verschuren L., de Vries-Van der Weij J., van der Hoorn J., Princen H.M., Kooistra T. Mouse models for atherosclerosis and pharmaceutical modifiers. Arterioscler. Thromb. Vasc. Biol. 2007, 27:1706-1721.